253 related articles for article (PubMed ID: 17268250)
21. Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?
Patoulias D
J Clin Transl Hepatol; 2021 Aug; 9(4):454-455. PubMed ID: 34447672
[No Abstract] [Full Text] [Related]
22. RETRACTION: Leukocyte cell-derived chemotaxin 2 affects nonalcoholic fatty liver disease.
Wang Y; Wu A; Xi L; Yang J; Zhou W; Wang Y; Liang S; Yu W; Wang Y; Zhu J
J Endocrinol; 2020 Sep; 246(3):Z1. PubMed ID: 32485675
[No Abstract] [Full Text] [Related]
23. Changes in the Dynamic Trajectory of Remnant Cholesterol Affect the Occurrence of Nonalcoholic Fatty Liver Disease.
Miao X; Hu M; Wang Q; Tang G; Leng S
Eur J Intern Med; 2024 Mar; ():. PubMed ID: 38485637
[No Abstract] [Full Text] [Related]
24. Treatment of Fatty Liver Disease-Time to Implement Common Sense Measures.
Adler E; Brandman D
JAMA Intern Med; 2019 Sep; 179(9):1272-1273. PubMed ID: 31260055
[No Abstract] [Full Text] [Related]
25. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic fatty liver disease: a systematic review.
Rinella ME
JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
[TBL] [Abstract][Full Text] [Related]
27. Steatohepatitis: a tale of two "hits"?
Day CP; James OF
Gastroenterology; 1998 Apr; 114(4):842-5. PubMed ID: 9547102
[No Abstract] [Full Text] [Related]
28. Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome.
Wang HH; Lee DK; Liu M; Portincasa P; Wang DQ
Pediatr Gastroenterol Hepatol Nutr; 2020 May; 23(3):189-230. PubMed ID: 32483543
[TBL] [Abstract][Full Text] [Related]
29. Secondhand Smoke Induces Liver Steatosis through Deregulation of Genes Involved in Hepatic Lipid Metabolism.
Tommasi S; Yoon JI; Besaratinia A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075112
[TBL] [Abstract][Full Text] [Related]
30. DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease.
Tommasi S; Besaratinia A
Int J Environ Res Public Health; 2019 Aug; 16(15):. PubMed ID: 31387232
[TBL] [Abstract][Full Text] [Related]
31. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
[TBL] [Abstract][Full Text] [Related]
32. Coupling of COPII vesicle trafficking to nutrient availability by the IRE1α-XBP1s axis.
Liu L; Cai J; Wang H; Liang X; Zhou Q; Ding C; Zhu Y; Fu T; Guo Q; Xu Z; Xiao L; Liu J; Yin Y; Fang L; Xue B; Wang Y; Meng ZX; He A; Li JL; Liu Y; Chen XW; Gan Z
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11776-11785. PubMed ID: 31123148
[TBL] [Abstract][Full Text] [Related]
33. Effect of Phyllanthus emblica L. fruit on methionine and choline-deficiency diet-induced nonalcoholic steatohepatitis.
Tung YT; Huang CZ; Lin JH; Yen GC
J Food Drug Anal; 2018 Oct; 26(4):1245-1252. PubMed ID: 30249323
[TBL] [Abstract][Full Text] [Related]
34. Probiotic Therapy in Patients with Nonalcoholic Steatohepatitis in Zagazig University Hospitals.
Abdel Monem SM
Euroasian J Hepatogastroenterol; 2017; 7(1):101-106. PubMed ID: 29201787
[TBL] [Abstract][Full Text] [Related]
35. The current status of bariatric surgery.
Pollard S
Frontline Gastroenterol; 2011 Apr; 2(2):90-95. PubMed ID: 28839589
[TBL] [Abstract][Full Text] [Related]
36. Aggressive Crosstalk Between Fatty Acids and Inflammation in Macrophages and Their Influence on Metabolic Homeostasis.
Nishiyama K; Fujimoto Y; Takeuchi T; Azuma YT
Neurochem Res; 2018 Jan; 43(1):19-26. PubMed ID: 28424949
[TBL] [Abstract][Full Text] [Related]
37. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
38. Influence of Roux-en-Y Gastric Bypass on the Hepatocellular Function and Bile Flow of Obese Patients Assessed by Scintigraphy with DISIDA.
Salgado Júnior W; Donadelli CA; Dos Santos JS; Nonino CB
Obes Surg; 2016 Nov; 26(11):2718-2723. PubMed ID: 27094876
[TBL] [Abstract][Full Text] [Related]
39. Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese.
Pardina E; Ferrer R; Rossell J; Baena-Fustegueras JA; Lecube A; Fort JM; Caubet E; González Ó; Vilallonga R; Vargas V; Balibrea JM; Peinado-Onsurbe J
BBA Clin; 2016 Jun; 5():54-65. PubMed ID: 27051590
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
